Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

Bibliographic Details
Main Authors:	Hitoshi Tajiri, Satoshi Motoya, Fukunori Kinjo, Atsuo Maemoto, Takayuki Matsumoto, Noriko Sato, Hiroshi Yamada, Mieko Nagano, Yutaka Susuta, Kunihiko Ozaki, Kazuoki Kondo, Toshifumi Hibi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017882/?tool=EBI

Similar Items

Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan
by: Hitoshi Tajiri, et al.
Published: (2019-10-01)

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
by: Tadakazu Hisamatsu, et al.
Published: (2018-07-01)

Infliximab in Crohn's disease
by: L. Rodrigo Sáez

A Food Impaction in Crohn’s Ileal Stricture
by: Hokama, Akira, et al.
Published: (2010-02-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01)

Tratamento da doença de Crohn com infliximabe: primeira opção? Treatment of Crohn's disease with infliximab: first choice?
by: Anna Paula Rocha Malheiros, et al.
Published: (2009-06-01)

Infliximab- and Immunosuppressant-Resistant Crohn’s Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone
by: Munenori Itagaki, et al.
Published: (2012-02-01)

Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
by: Diana Carvalho, et al.
Published: (2017-09-01)

Metastatic Crohn’s disease despite infliximab therapy
by: Sara Campos, et al.
Published: (2017-01-01)

Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
by: Aibar Aginbay, et al.
Published: (2022-11-01)

Infliximab-induced intertriginous psoriasis in patient with Crohn's desease
by: Federica Mola, et al.
Published: (2011-10-01)

Infliximab-induced psoriasis in a patient with crohn′s disease
by: Iqbal Bukhari, et al.
Published: (2015-01-01)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
by: You Lim Kim, et al.
Published: (2014-01-01)

Profile of infliximab in the treatment of pediatric Crohn’s disease
by: Kierus J, et al.
Published: (2015-06-01)

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
by: Toshifumi Hibi, et al.
Published: (2019-07-01)

Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study.
by: Tomoe Kazama, et al.
Published: (2023-01-01)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
by: Dario Sorrentino, et al.
Published: (2015-01-01)

Cortical Vein Thrombosis after Infliximab Treatment for Crohn’s Disease
by: Saeed Razmeh, et al.
Published: (2021-03-01)

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease
by: Shuyan Li, et al.
Published: (2023-08-01)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
by: Mitsuro Chiba, et al.
Published: (2019-08-01)

Azathioprine and Infliximab: Monotherapy or Combination Therapy in the Treatment of Crohn's Disease
by: Bryan L. Love, et al.
Published: (2011-01-01)

Closure of enterovesical fistula in Crohn’s disease with infliximab: case report
by: Flávio Steinwurz
Published: (2003-03-01)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
by: Jong Pil Im
Published: (2017-04-01)

Predictors of response to infliximab in patients with fistulizing Crohn's disease Factores predictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante
by: M. Luna-Chadid, et al.
Published: (2004-06-01)

Monitoring of leucine‐rich alpha‐2‐glycoprotein and assessment by small bowel capsule endoscopy are prognostic for Crohn's disease patients
by: Takahiro Ito, et al.
Published: (2023-09-01)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
by: Hyder, SA, et al.
Published: (2006)

Infliximab use in Crohn's disease: impact on health care resources in the UK.
by: Jewell, D, et al.
Published: (2005)

The use of infliximab in South-east Asian children with severe Crohn's disease
by: Lee, W.S.
Published: (2004)

Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
by: Ye Ma, et al.
Published: (2023-03-01)

Demodicosis as an opportunistic infection in a patient with Crohn’s disease treated with infliximab
by: Michał Niedźwiedź, et al.
Published: (2022-09-01)

Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
by: Song Christine H, et al.
Published: (2012-11-01)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
by: W. Clark, et al.
Published: (2003-01-01)

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
by: Jessica R de Bruyn, et al.
Published: (2018-01-01)

B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
by: Wilhelmina M C Timmermans, et al.
Published: (2016-01-01)

Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
by: Hye-In Jung, et al.
Published: (2021-01-01)

Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
by: Carlos Henrique Marques dos Santos
Published: (2014-07-01)

Infliximab therapy in pediatric Crohn&rsquo;s disease: a review
by: Kalyan Ray Parashette, et al.
Published: (2010-06-01)